This company has been marked as potentially delisted and may not be actively trading. Genesis Healthcare (GEN) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrendsBuy This Stock GEN vs. SNOW, ADSK, NET, TEAM, RBLX, TTWO, DDOG, VEEV, EA, and XYZShould you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Snowflake (SNOW), Autodesk (ADSK), Cloudflare (NET), Atlassian (TEAM), Roblox (RBLX), Take-Two Interactive Software (TTWO), Datadog (DDOG), Veeva Systems (VEEV), Electronic Arts (EA), and Block (XYZ). These companies are all part of the "prepackaged software" industry. Genesis Healthcare vs. Snowflake Autodesk Cloudflare Atlassian Roblox Take-Two Interactive Software Datadog Veeva Systems Electronic Arts Block Snowflake (NYSE:SNOW) and Genesis Healthcare (NYSE:GEN) are both large-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Do institutionals & insiders hold more shares of SNOW or GEN? 65.1% of Snowflake shares are held by institutional investors. Comparatively, 82.1% of Genesis Healthcare shares are held by institutional investors. 7.8% of Snowflake shares are held by insiders. Comparatively, 3.3% of Genesis Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable valuation and earnings, SNOW or GEN? Genesis Healthcare has lower revenue, but higher earnings than Snowflake. Snowflake is trading at a lower price-to-earnings ratio than Genesis Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSnowflake$3.84B17.60-$836.10M-$4.21-48.08Genesis Healthcare$2.80B6.40$836M$0.9031.11 Do analysts prefer SNOW or GEN? Snowflake currently has a consensus price target of $217.33, suggesting a potential upside of 7.38%. Genesis Healthcare has a consensus price target of $32.00, suggesting a potential upside of 14.29%. Given Genesis Healthcare's higher possible upside, analysts clearly believe Genesis Healthcare is more favorable than Snowflake.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Snowflake 2 Sell rating(s) 7 Hold rating(s) 31 Buy rating(s) 2 Strong Buy rating(s) 2.79Genesis Healthcare 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Is SNOW or GEN more profitable? Genesis Healthcare has a net margin of 17.83% compared to Snowflake's net margin of -33.02%. Genesis Healthcare's return on equity of 155.48% beat Snowflake's return on equity.Company Net Margins Return on Equity Return on Assets Snowflake-33.02% -24.23% -13.30% Genesis Healthcare 17.83%155.48%9.12% Does the media refer more to SNOW or GEN? In the previous week, Snowflake had 69 more articles in the media than Genesis Healthcare. MarketBeat recorded 69 mentions for Snowflake and 0 mentions for Genesis Healthcare. Snowflake's average media sentiment score of 0.86 beat Genesis Healthcare's score of 0.00 indicating that Snowflake is being referred to more favorably in the media. Company Overall Sentiment Snowflake Positive Genesis Healthcare Neutral Does the MarketBeat Community prefer SNOW or GEN? Genesis Healthcare received 177 more outperform votes than Snowflake when rated by MarketBeat users. Likewise, 65.43% of users gave Genesis Healthcare an outperform vote while only 53.50% of users gave Snowflake an outperform vote. CompanyUnderperformOutperformSnowflakeOutperform Votes29853.50% Underperform Votes25946.50% Genesis HealthcareOutperform Votes47565.43% Underperform Votes25134.57% Which has more risk and volatility, SNOW or GEN? Snowflake has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. SummaryGenesis Healthcare beats Snowflake on 10 of the 19 factors compared between the two stocks. Get Genesis Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GEN vs. The Competition Export to ExcelMetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE ExchangeMarket Cap$17.90B$26.64B$24.37B$19.45BDividend Yield3.05%1.73%2.66%3.90%P/E Ratio31.11117.4733.4134.73Price / Sales6.4015.38363.0041.78Price / Cash8.4286.0630.9317.51Price / Book-175.009.405.434.74Net Income$836M$436.62M$195.65M$1.02B Genesis Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENGenesis Healthcare1.4605 of 5 stars$28.00-0.2%$32.00+14.3%+14.5%$17.90B$2.80B31.112,700SNOWSnowflake3.7675 of 5 stars$199.99-1.6%$217.33+8.7%+36.2%$66.02B$3.84B-58.993,990Trending NewsInsider TradeOptions VolumeADSKAutodesk4.3906 of 5 stars$295.35+0.1%$337.18+14.2%+42.4%$63.19B$6.13B58.6012,600Trending NewsAnalyst ForecastNETCloudflare3.9056 of 5 stars$158.45+0.1%$141.79-10.5%+118.7%$54.68B$1.77B-720.203,220Positive NewsInsider TradeShort Interest ↑TEAMAtlassian4.875 of 5 stars$206.82-0.7%$285.29+37.9%+23.0%$54.29B$4.96B-154.348,810Analyst UpgradeInsider TradeShort Interest ↓Gap DownRBLXRoblox2.2666 of 5 stars$82.26+0.6%$68.68-16.5%+156.1%$51.82B$3.84B-56.732,130Positive NewsAnalyst ForecastInsider TradeShort Interest ↑Gap DownTTWOTake-Two Interactive Software4.0121 of 5 stars$224.99-0.5%$228.10+1.4%+41.2%$39.92B$5.63B-10.557,800DDOGDatadog4.7012 of 5 stars$114.46-1.0%$141.54+23.7%-3.8%$39.53B$2.83B224.444,800Positive NewsVEEVVeeva Systems3.6729 of 5 stars$233.41-0.9%$254.92+9.2%+39.1%$37.97B$2.75B57.635,480Trending NewsEarnings ReportAnalyst ForecastOptions VolumeGap UpEAElectronic Arts4.5609 of 5 stars$146.89+0.2%$161.29+9.8%+8.2%$36.84B$7.46B37.3812,900Trending NewsAnalyst ForecastXYZBlock4.3572 of 5 stars$58.77+0.7%$75.52+28.5%N/A$36.14B$23.94B12.9212,985Analyst ForecastInsider Trade Related Companies and Tools Related Companies SNOW Alternatives ADSK Alternatives NET Alternatives TEAM Alternatives RBLX Alternatives TTWO Alternatives DDOG Alternatives VEEV Alternatives EA Alternatives XYZ Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GEN) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk’s Frightening Warning Forces Trump’s HandElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored"I'm risking my reputation on this"The Secret Behind 90% of Crypto’s Biggest Gains There are plenty solution-driven opportunities emerging rig...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
